Total
0
Shares
Alcidion Group (ASX:ALC) - Managing Director, Kate Quirke
Managing Director, Kate Quirke
Source: Finfeed
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Alcidion Group (ALC) has signed a 12-month, $560,000 contract with Sydney Local Health District (LHD) for its Miya Precision platform
  • Miya Precision combines AI-based predictive analysis, clinical support, and mobile alerts in an easy-to-use dashboard
  • This contract will see Miya Precision be deployed to Sydney LHD’s virtual hospital which is being used for COVID-19 positive patients who are in home isolation
  • Patients will have their statuses displayed in real-time, as well as other relevant information to allow for the best possible care
  • Alcidion is up 10.3 per cent on the market and shares are currently trading for 16 cents each

Alcidion Group (ALC) has signed a 12-month, $560,000 contract with Sydney Local Health District (LHD) for its Miya Precision platform.

Miya Precision combines AI-based predictive analysis, clinical support, and mobile alerts in an easy-to-use dashboard.

This contract will see the Miya Precision platform be deployed to Sydney LHD’s virtual hospital, rpavirtual, which is being used for COVID-19 positive patients who are in home isolation.

“Miya Precision has the potential to provide valuable support for some critical short-term requirements for Sydney LHD, but also provides us with a platform to continue to innovate the delivery of patient care across the entire district,” Sydney LHD Chief Information Officer Richard Taggart said.

Patients will have their statuses displayed in real-time, as well as other relevant information to allow for the best possible care.

This reduces the risk of infection for healthcare workers, and the need for personal protective equipment (PPE).

“We are delighted to enter into this partnership with Sydney LHD. We have moved quickly to enable an initial rollout that addresses the short-term challenges raised by COVID-19,” Alcidion Managing Director Kate Quirke commented.

“The engagement allows us to demonstrate the value of our platform in one of the busiest hospitals in Australia operating across metropolitan Sydney, in the same way as we have done with the deployment at Murrumbidgee LHD for the rural sector,” she added.

Alcidion is up 10.3 per cent on the market and shares are trading for 16 cents each at 1:39 pm AEST.

ALC by the numbers
More From The Market Herald
Dimerix (ASX:DXB) - Managing Director and CEO, Nina Webster

" Dimerix (ASX:DXB) expands DMX-200 study into Australia

Dimerix (DXB) has entered an agreement with the NHMRC Clinical Trials Centre at the University of Sydney to expand the CLARITY 2.

" ACCC scrambles to halt Virtus Health’s (ASX:VRT) purchase of Healius (ASX:HLS) IVF clinics

The ACCC has taken “a significant step” as it seeks an urgent injunction to stop Virtus Health’s (VRT) proposed acquisition of Adora Fertility
IDT Australia (ASX:IDT) - Chair, Alan Fisher

" IDT Australia (ASX:IDT) signs manufacturing deal with Monash University

IDT Australia (IDT) has entered a master services agreement and services order with Monash University.
Prescient Therapeutics (PTX) - CEO and MD, Steven Yatomi Clarke

" Prescient Therapeutics (ASX:PTX) to present new OmniCAR data at conference

Prescient Therapeutics (PTX) will present new results for its OmniCAR drug at the Cell & Gene Meeting on Mesa in California.